Sreelakshmi24’s Blog

where life is all about learning

Archive for the ‘Piramal Healthcare’ Category

Piramal Healthcare honours the best interventional cardiologists in India

with 2 comments

Piramal Healthcare Limited, one of India’s largest pharmaceutical companies, awarded the ‘Piramal Knowledge Academy Best Intervention Award 2009‘ to four eminent interventional cardiologists at the National Intervention Council (NIC) on April 26, 2009 in Hyderabad. Around 500 interventional cardiologists attended the program. Dr. Sarat Chandra, Chairman, National Intervention Council was instrumental in integrating this award in NIC. He presided over the conference and headed the jury that chose the winners.

Piramal Knowledge Academy supports the cause of the Percutaneous Transluminal Coronary Angioplasty (PTCA) Registry and is aimed at promoting unique Percutaneous Coronary Intervention (PCI) by interventional cardiologists. PTCA Registry is a mid-term scientific fiesta which is organised every year, where more than 100 pre-selected cases are shown and discussed for everyone’s benefit over the course of the three days of the Registry. Piramal Knowledge Academy will continue to honour and acknowledge the best angioplasty cases in the country every year.

Piramal Knowledge Academy conducts a host of Advisory Panel Programmes, Skill Upgradation Programmes and Collaborative Educational Programmes with the medical fraternity. Dr. Swati Piramal, Director Communications & Strategic Alliances, Piramal Healthcare Limited said, “Piramal Knowledge Academy was conceptualized with the belief that sharing of knowledge with the medical fraternity is an imperative to alleviate the lives of the end patients and thereby the status of healthcare in India. It is our humble attempt at recognizing and felicitating stellar achievements in interventional cardiology.”

The winners of the prestigious award this year are:

  • Dr. Navneet Singh from AIIMS, Delhi for his unusual case of CoArc dilatation,
  • Dr. Bhanu from J.J. Medical College, Mumbai for her case on ballooning and stenting in peripheral and pulmonary artery stenosis,
  • Dr. Pankaj Jariwalla from Nizam’s Institute of Medical Sciences, Hyderabad for his case on left systemic artery to pulmonary vein AV valve formation, closed by vascular plug & coil embolisation and
  • Dr. Harikrishna from Shri Chitra Institute of Medical Sciences, Trivandrum for Ductal stenting in a neonate. The winners were honoured with a monetary award of Rs. 20,000, a certificate and an annual print subscription to an international health journal of repute.

The medical fraternity unreservedly appreciated this initiative from Piramal Healthcare. “It is a great honour for me to receive this award,” said Dr. Harikrishnan.

Advertisements

Mumbai High Court Order Against Firms Selling Counterfeits of Piramal Healthcare’s Esgipyrin

with one comment

Piramal Healthcare Ltd. obtained a common ex-parte ad-interim order from the Mumbai High Court on Thursday, April 9, 2009 restraining four companies from using trademarks similar to its product Esgipyrin. Piramal Healthcare is a registered proprietor of the mark ‘Esgipyrin’ and the company has been using the trademark since 1974.

The four companies that have been restrained via this order are:

  • Endolabs Healthcare Pvt. Ltd., for their trademark Easipyrin
  • Endolabs Lifescience, for their trademark Elgipyrin
  • Spachem Laboratories Pvt. Ltd., for their trademark Zypyrine
  • Endolabs Ltd., for their trademark Agepyrine

The order states that the companies have introduced the infringing products for the same ailment as countered by Piramal’s Esgipyrin and that it has been prima facie seen that the product is deceptively similar to that of the original product. The order further goes on to state that the companies have been engaged in a deliberate, dishonest and fraudulent act of counterfeiting and are passing off their products as that from Piramal Healthcare.

A counterfeit drug is a medication or pharmaceutical product which is produced and sold with the intent to deceptively represent its origin, authenticity or effectiveness. The prevalence of counterfeit drugs appears constantly to be on the rise and these drugs are a major cause of morbidity, mortality, and loss of public confidence in medicines, the manufacturers and the overall health structures.

Written by sreelakshmi

15 April, 2009 at 5:38 pm

Nandini Piramal joins Piramal Healthcare as the Executive Director

leave a comment »

Piramal Healthcare Limited has announced the appointment of Ms. Nandini Piramal on the Board of the company as the Executive Director. Nandini Piramal has been associated with the business for last four years looking after the operations in Canada. Nandini Piramal is the daughter of the promoters Mr. Ajay Piramal and Dr. Swati Piramal.

Prior to her induction on the Board of Piramal Group, Nandini Piramal was the GM – Strategic Marketing of Piramal Healthcare, during which she was closely associated with the business of the company’s overseas subsidiaries and gained deep insight into the Group’s Pharma Solutions business. She played a key role in implementation of Operational Excellence Projects at the company’s overseas locations in UK and Canada. She was also actively involved in due diligence of acquisition and joint venture targets.

Ms. Piramal is a graduate in BA (Hons.) from Hertford College, Oxford University and is an MBA from the Stanford Graduate School of Business. In her role as a Business Analyst with a leading management consulting firm she worked on projects in Growth Strategy, Supply Chain Management and Information Technology Strategy of various corporate clients.


Mr. Ajay Piramal is the India Innovator of the Year

leave a comment »

Mr. Ajay Piramal, Chaiman, Piramal Healthcare was adjudged as the India Innovator Of The Year at the CNBC-TV18 India Business Leader Awards presented by Accenture. The award ceremony saw the best in Indian Business come together to salute the finest in Corporate India. Held in Mumbai the awards were graced by the presence of Shri. Kamal Nath, Union Minister of Commerce and Industries, Shri. Ashok Chavan, Chief Minister, Maharashtra, Shri.
Narendra Modi, Chief Minister, Gujarat among others who felicitated the winners.

While accepting the honour, Mr. Piramal said that the task before us is immense. He also hoped that India would be able to invent a drug, a feat that still eludes the country.

The 4th CNBC-TV18 India Business Leader Awards, India’s most definitive awards in business excellence, felicitated the visionaries who have set shining examples in business leadership over the years. The winners were judged by business leaders
like Mr. Mukesh Ambani, Reliance Industries Ltd. (Chairperson, Jury), Mr. Kumar Mangalam Birla, Chairman, Aditya Birla Group, Mr. Deepak Parekh, Chairman, HDFC, Mr. R. Seshasayee, Managing Director, Ashok Leyland, Mr. Jagdish Khattar, CMD, Carnation Auto India Pvt. Ltd. and Mr.
Raghav Bahl, MD, Network18.

Talking on the parameters on which the winners were selected, Mr. Ambani said, “A leader has to navigate the path and protect the interests of all the stakeholders in a consistent way so that they can deliver performance on an ongoing basis. Also Execution and accomplishments were the main considerations.” According to Mr. Birla, track record is important. Long term viability and sustainability of the business model is also vital. Mr Parekh believes that individual contribution to the company is very important especially in troubled times like these.

Speaking about the awards, Mr. Ajay Chacko, Director, TV18, Business Media said, “India Business Leader Awards are an unparalleled tribute to the excellence in business in India. The awards have become in institution by itself and the winners epitomize strength, ingenuity, knowledge, foresight and who drive the growth of their businesses with vision and inspiration.”